Deliberate Self-poisoning with dapSOne a case report and summary of relevant pharmacology and treatment

Anaesthesia

Volumn 52, Issue 4, 1997, Pages 359-363

  Ferguson, A J ^a   Lavery, G G ^b  

^a NATIONAL HEALTH SERVICE   (United Kingdom)

^b ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

Complications; Dapsone; Pharmacology

Indexed keywords

DAPSONE; METHYLENE BLUE;

ADOLESCENT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG OVERDOSE; FEMALE; HUMAN; MENTAL HEALTH; METHEMOGLOBINEMIA;

EID: 0030934202     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2044.1997.98-az0094b.x     Document Type: Article

References (22)

1. Erstad BL. Dapsone-induced methemoglobinemia and hemolytic anemia. Clinical Pharmacy 1992; 11: 800-5.
2. Chawla R, Gurnani A, Bhattacharya A. Acute dapsone poisoning. Anaesthesia and Intensive Care 1993; 21: 349-51.
3. Hansen DG, Challoner KR, Smith DE. Dapsone intoxication: two case reports. Journal of Emergency Medicine 1994; 12: 347-51.
4. Sheela A, Thachil RT, Sridhar CB. Dapsone poisoning. Journal of Tropical Medicine and Hygiene 1993; 96: 274-6.
5. Elonen E, Neuvonen PJ, Halmekoski J, Mattila MJ. Acute dapsone intoxication. A case with prolonged symptoms. Clinical Toxicology 1979; 14: 79-85.
6. Sturt J. Too much of a good thing. Papua New Guinea Medical Journal 1967; 10: 97.
7. Ellenhorn MJ, Barceloux DG. Medical Toxicology Diagnosis and Treatment of Human Poisoning. New York: Eisevier, 1988.
8. Coleman MD. Dapsone: modes of action, toxicity and possible strategies for increasing tolerance. British Journal of Dermatology 1993; 129: 507-13.
9. McKenna WB, Chalmers AC. Agranulocytosis following dapsone therapy. British Medical Journal 1958; 1: 324-5.
10. Booth SA, Moody CE, Dahl MV, Herron MJ, Nelson RD. Dapsone suppresses integrin-mediated neutrophil adherence function. Journal of Investigative Dermatology 1992; 98: 135-40.
11. Hall AH, Kulig KW, Rumack BH. Drug- and chemicalinduced methaemoglobinaemia -clinical features and management. Medical Toxicology 1986; 1: 253-60.
12. Rasbridge MR, Scott G. The haemolytic action of dapsone: changes in the red cell membrane. British Journal of Haematology 1973; 24: 183-93.
13. Kenner DJ, Holt K, Agnello R, Chester GH. Permanent retinal damage following massive dapsone overdose. British Journal of Ophthalmology 1980; 64: 741-4.
14. Berlin G, Brodi B, Hilden J-O, Martensson J. Acute dapsone intoxication: a case treatment with continuous infusion of méthylène blue, forced diuresis and plasma exchange. Clinical Toxicology 1984/85; 22: 537-48.
15. Jaffe E. Hereditary methaemoglobinaemia associated with abnormalities in the metabolism of erythrocytes. American Journal of Mediane 1966; 41: 786-98.
16. Whitwam JG, Taylor AR, White JM. Potential hazard of méthylène blue. Anaesthesia 1979; 34: 181-2.
17. Kumar A, Antony TJ, Kurein KM, Taneja LN, Mohan M, Anand NK. Exchange transfusion for dapsone poisoning. Indian Paediatrics 1988; 25: 798-800.
18. Endre ZH, Charlesworth JA, Macdonald GJ, Woodbridge L. Successful treatment of acute dapsone intoxication using charcoal haemoperfusion. Australian and New Zealand Journal of Medicine 1983; 13: 509-12.
19. Neuvonen PJ, Elonen E, Haapanen EJ. Acute dapsone intoxication: clinical findings and effect of oral charcoal and haemodialysis on dapsone elimination. Acta Med. Scandinavica 1983; 244: 215-20.
20. Prussick R, Ali MA, Rosenthal D, Guyatt G. The protective effect of Vitamin E on the haemolysis associated with dapsone treatment in patients with dermatitis herpetifonnis. Archives of Dermatology 1992; 128: 210-3.
21. Coleman MD, Rhodes LE, Scott AK, Verbov JL, Friedmann PS. The use of cimetidine to reduce dapsonedependent methaemoglobinaemia in dermatitis herpetiformis patients. British Journal of Clinical Pharmacology 1992; 34: 244-9.
22. Rhodes LE, Tingle MD, Park BK, Chu P, Verbov JL, Friedmann PS. Cimetidine improves the therapeutic/toxic ratio of dapsone in patients on chronic dapsone therapy. British Journal of Dermatology 1995; 132: 257-62.